Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Dr Shingo Fujii talks to ecancer at the 2012 International Gynaecologic Cancer Society meeting in Vancouver about the controversy around radical hysterectomy and the precise anatomy involved in the surgical treatment to prevent complications.
Filming supported by Amgen
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Laser oncosurgery - A new perspective in treating cancer
Choosing the right patients for transplant
Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy without impacting survival outcomes
Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours
Gynaecological cancer: New targets and immunotherapy developments
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients
The role of lymph nodes in stage 3 lung cancer